Svas Biosana S.p.A. (BIT:SVS)
9.80
-0.10 (-1.01%)
At close: Oct 31, 2025
Svas Biosana Revenue
Svas Biosana had revenue of 71.70M EUR in the half year ending June 30, 2025, with 26.06% growth. This brings the company's revenue in the last twelve months to 134.95M, up 9.02% year-over-year. In the year 2024, Svas Biosana had annual revenue of 122.29M with 0.54% growth.
Revenue (ttm)
134.95M
Revenue Growth
+9.02%
P/S Ratio
0.39
Revenue / Employee
385.58K
Employees
327
Market Cap
52.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 122.29M | 656.90K | 0.54% |
| Dec 31, 2023 | 121.63M | 22.12M | 22.22% |
| Dec 31, 2022 | 99.51M | 17.52M | 21.37% |
| Dec 31, 2021 | 81.99M | 4.72M | 6.11% |
| Dec 31, 2020 | 77.27M | -23.22M | -23.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.48B |
| Amplifon | 2.41B |
| DiaSorin | 1.22B |
| Safilo Group | 998.89M |
| EL.En. | 579.71M |
| Pharmanutra | 122.25M |
| Philogen | 84.66M |
| Farmacosmo | 59.23M |